Company intelligence / Profile preview

成都串串

Chengdu, Sichuan, Chinam.pearvideo.com ↗

Ownership: Private
Development stage: Other

Overview

Sichuan Kelun Pharmaceutical is a leading Chinese pharmaceutical manufacturer headquartered in Chengdu. It develops and markets a broad portfolio of products including large-volume infusions, antibiotics, oncology therapies (notably antibody-drug conjugates), parenteral nutrition solutions, APIs, and medical devices. The company has more than 170 clinical trials conducted or ongoing and over 110 commercialized drugs. Recent strategic partnerships include major global deals to co-develop antibody-drug conjugates with Merck for cancer treatment.

Therapeutic areas: OncologyGastroenterologyInfectious Diseases
Modalities: Small moleculeBiologicAntibody-drug conjugateAntibioticInfusion product
Industry: Biotech

Partnerships

Merck & Co. (antibody-drug conjugate R&D collaboration)

Beyond the preview

Go deeper on 成都串串.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 成都串串.

Explore the full profile